Research Topics
| Andrew D BarretoSummaryAffiliation: Baylor College of Medicine Country: USA Publications
| Collaborators
|
Detail Information
Publications
The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety studyAndrew D Barreto
Department of Neurology, University of Texas Houston Medical School, Houston, TX, USA
Stroke 43:770-5. 2012..The Argatroban tPA Stroke Study was an open-label, pilot safety study of tPA plus Argatroban in patients with ischemic stroke due to proximal intracranial occlusion...- Adjunctive and alternative approaches to current reperfusion therapyAndrew D Barreto
Department of Neurology, Program, The University of Texas Houston Medical School, Houston, TX, USA
Stroke 43:591-8. 2012..Patients who fail to rapidly reperfuse may benefit from other strategies that maintain collateral flow or protect tissue at risk... - Thrombus burden is associated with clinical outcome after intra-arterial therapy for acute ischemic strokeAndrew D Barreto
Department of Neurology, Stroke Division, University of Texas, Houston Health Science Center, Houston, TX 77030, USA
Stroke 39:3231-5. 2008..The aim of the study was to determine the impact of intra-arterial thrombus burden on intra-arterial treatment (IAT) and clinical outcome... - Thrombolytic therapy for patients who wake-up with strokeAndrew D Barreto
Stroke Division, Department of Neurology, University of Texas Houston Medical School, Houston, USA
Stroke 40:827-32. 2009..The purpose of this study was to describe our center's experience with off-label, compassionate thrombolysis for wake-up stroke (WUS) patients... - Intravenous thrombolytics for ischemic strokeAndrew D Barreto
Department of Neurology, Stroke Division, Neurosonology Laboratory, University of Texas Houston Medical School, Houston, TX 77030, USA
Neurotherapeutics 8:388-99. 2011..Adjunctive treatments are also being evaluated. The challenge remains balancing reperfusion and salvaging brain tissue with the potential risks of brain hemorrhage... - Does study enrollment delay treatment with intravenous thrombolytics for acute ischemic stroke?Sheryl Martin-Schild
Department of Neurology, University of Texas Medical SchoolHouston Medical School, Houston, Texas 77030, USA
Stroke 40:663. 2009..Enrollment in acute stroke trials at a stroke center with multiple study protocols may delay the initiation of intravenous thrombolytics in patients who present within 3 hours of symptom onset... 
Recovery after ischemic stroke: criteria for good outcome by level of disability at day 7Hen Hallevi
Department of Neurology, Vascular Neurology Program, University of Texas at Houston Health Science Center, Houston, Texas 77030, USA
Cerebrovasc Dis 28:341-8. 2009..Ischemic stroke is a leading cause of morbidity. Assessing the chances of recovery is critical to optimize poststroke care...- Anticoagulation after cardioembolic stroke: to bridge or not to bridge?Hen Hallevi
Department of Neurology, University of Texas Health Science Center at Houston, 6431 Fannin St, MSB 7 044, Houston, TX 77030, USA
Arch Neurol 65:1169-73. 2008..Outcome measures and adverse events were collected prospectively. Laboratory values were captured from the records... - Is the drip-and-ship approach to delivering thrombolysis for acute ischemic stroke safe?Sheryl Martin-Schild
Department of Neurology, University of Texas Houston Health Science Center, Houston, Texas, USA
J Emerg Med 41:135-41. 2011..The drip-and-ship method of treating stroke patients may increase the use of tissue plasminogen activator (t-PA) in community hospitals... - Combined neuroprotective modalities coupled with thrombolysis in acute ischemic stroke: a pilot study of caffeinol and mild hypothermiaSheryl Martin-Schild
Department of Neurology, University of Texas Houston Medical School, Houston, TX, USA
J Stroke Cerebrovasc Dis 18:86-96. 2009..We tested whether combining caffeinol and hypothermia with tissue plasminogen activator (t-PA) in patients with acute stroke is safe and feasible... - Safety of eptifibatide for subcortical stroke progressionSheryl Martin-Schild
Department of Neurology, University of Texas Houston Medical School, Houston, TX, USA
Cerebrovasc Dis 28:595-600. 2009..There is no proven treatment for stroke progression in patients with subcortical infarcts. Eptifibatide, a glycoprotein IIb/IIIa inhibitor, might halt stroke progression by improving flow in the microcirculation... - Identifying patients at high risk for poor outcome after intra-arterial therapy for acute ischemic strokeHen Hallevi
Department of Neurology, University of Texas Health Science Center at Houston, Houston, TX 77030, USA
Stroke 40:1780-5. 2009..Despite high rates of recanalization, the outcome is variable. We attempted to identify predictors of outcome that will enable better patient selection for IAT... - Aggressive blood pressure-lowering treatment before intravenous tissue plasminogen activator therapy in acute ischemic strokeSheryl Martin-Schild
Vascular Neurology Program, Department of Neurology, University of Texas Health Science Center at Houston, 6431 Fannin St, Medical School Bldg Room 7 128, Houston, TX 77030, USA
Arch Neurol 65:1174-8. 2008..We evaluated the effect of elevated BP and its management on clinical outcomes after tPA therapy in AIS... - The IVH score: a novel tool for estimating intraventricular hemorrhage volume: clinical and research implicationsHen Hallevi
Department of Neurology, University of Texas Health Science Center at Houston, Houston, TX, USA
Crit Care Med 37:969-74, e1. 2009..Intraventricular extension of intracerebral hemorrhage (IVH) is an independent predictor of poor outcome. IVH volume may be important in outcome prediction and management; however, it is difficult to measure routinely... - Pharmacological deep vein thrombosis prophylaxis does not lead to hematoma expansion in intracerebral hemorrhage with intraventricular extensionTzu Ching Wu
Department of Neurology, The University of Texas Houston Medical School, 6431 Fannin Street Suite, Houston, TX 77030, USA
Stroke 42:705-9. 2011..However, insufficient data exist on hematoma volume in patients with ICH before and after pharmacological deep venous thrombosis prophylaxis, leaving physicians with uncertainty regarding the safety of this practice... - Intracerebral hemorrhage in cocaine usersSheryl Martin-Schild
Department of Neurology, Tulane University, New Orleans, LA, USA
Stroke 41:680-4. 2010..Cocaine is a cause of intracerebral hemorrhage (ICH), but there are no large studies that have characterized the location, pathology, and outcome of patients with cocaine-associated ICH... - The complications of cardioembolic stroke: lessons from the VISTA databaseHen Hallevi
University of Texas at Houston, Vascular Neurology Program, Houston, Tex 77030, USA
Cerebrovasc Dis 26:38-40. 2008..Cardioembolic stroke (CES) accounts for 20-30% of ischemic strokes. We attempted to describe the complications of CES... - Safety and dose-escalation study design of Transcranial Ultrasound in Clinical SONolysis for acute ischemic stroke: the TUCSON TrialAndrew D Barreto
Department of Neurology, University of Texas Houston Stroke Team, Houston, TX, USA
Int J Stroke 4:42-8. 2009..The signal-of-efficacy is determined by rates of recanalization, dramatic or early clinical recovery within 2 h, clinical recovery at 24-36 h and independent outcome (mRS 0-2) at 90 days...